Which of the following medications is exempt from the Poison Prevention Packaging Act?

The Poison Prevention Packaging Act (PPPA) mandates that certain medications must be packaged in child-resistant containers to prevent accidental ingestion by children. However, there are specific exemptions. One of the key exemptions includes medications that are deemed less likely to be harmful in small dosages.

Nitrostat SL tablets contain nitroglycerin, which is used to treat angina and is taken in very low doses. Due to the critical nature of the drug for patients with heart conditions and the way it is administered, this medication is exempt from the packaging requirements of the PPPA. The rationale is that while it is important to keep medications out of children's reach, in this case, the risk of harm from unintended pediatric exposure is significantly lower given the dosage and required patient management.

In contrast, the other medications listed, such as Amoxicillin capsules, Ibuprofen tablets, and Hydrochlorothiazide tablets, do not fall under this exemption due to their broader potential risk or the higher likelihood that they could be harmful if ingested by children. This is why they are required to be packaged in child-resistant containers according to the regulations set by the PPPA.